{"PubmedArticleSet": {"PubmedArticle": [{"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "30980249"}, "DateCompleted": {"Year": "2020", "Month": "02", "Day": "26"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "26"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1880-4233"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "26", "Issue": "6", "PubDate": {"Year": "2019", "Month": "Nov"}}, "Title": "Breast cancer (Tokyo, Japan)", "ISOAbbreviation": "Breast Cancer"}, "ArticleTitle": "Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.", "Pagination": {"MedlinePgn": "846-851"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1007/s12282-019-00971-6"}, "Abstract": {"AbstractText": "Individuals carrying pathogenic BRCA1 or BRCA2 mutations have an increased lifetime risk of breast and/or ovarian cancer. The incidence of breast cancer amongst disease-free BRCA mutation carriers under surveillance and the clinical and pathological characteristics of those who subsequently develop the disease remain unclear in Japan. We reviewed the records of 155 individuals with BRCA1 or BRCA2 mutations identified by genetic testing between January 2000 and December 2016. At the time of genetic testing, 26 individuals with one of these mutations had no history of breast cancer and were therefore enrolled in a surveillance program that included biannual ultrasonography, clinical breast examination, annual mammography, and conditional magnetic resonance imaging for the early detection of primary breast cancer. During the surveillance period, 5 individuals with BRCA1 or BRCA2 mutations were diagnosed with primary breast cancer. The mean surveillance duration until breast cancer diagnosis was 48\u00a0months. The incidence of primary breast cancer during surveillance in initially disease-free BRCA mutation carriers was 4.23%/year. In two cases, the tumors were only detectable on MRI. The case 5 patient who presented with a tumor that was detected by self-examination, which then grew rapidly, had stage IIB triple-negative breast cancer. In conclusion, our results show that some challenges exist in the early detection of breast cancers in BRCA1 or BRCA2 mutation carriers. There are also some difficulties in approaching those individuals in Japanese society."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Shimada", "ForeName": "Satoko", "Initials": "S", "AffiliationInfo": [{"Affiliation": "Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan."}, {"Affiliation": "Department of Breast Oncology, Juntendo University, Tokyo, Japan."}]}, {"@ValidYN": "Y", "LastName": "Yoshida", "ForeName": "Reiko", "Initials": "R", "AffiliationInfo": {"Affiliation": "Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan. reiko.yoshida@jfcr.or.jp."}}, {"@ValidYN": "Y", "LastName": "Nakashima", "ForeName": "Eri", "Initials": "E", "AffiliationInfo": {"Affiliation": "Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan."}}, {"@ValidYN": "Y", "LastName": "Kitagawa", "ForeName": "Dai", "Initials": "D", "AffiliationInfo": {"Affiliation": "Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan."}}, {"@ValidYN": "Y", "LastName": "Gomi", "ForeName": "Naoya", "Initials": "N", "AffiliationInfo": [{"Affiliation": "Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan."}, {"Affiliation": "Diagnostic Imaging Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan."}]}, {"@ValidYN": "Y", "LastName": "Horii", "ForeName": "Rie", "Initials": "R", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan."}, {"Affiliation": "Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan."}]}, {"@ValidYN": "Y", "LastName": "Takeuchi", "ForeName": "Sayoko", "Initials": "S", "AffiliationInfo": {"Affiliation": "Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan."}}, {"@ValidYN": "Y", "LastName": "Ashihara", "ForeName": "Yuumi", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan."}}, {"@ValidYN": "Y", "LastName": "Kita", "ForeName": "Mizuho", "Initials": "M", "AffiliationInfo": {"Affiliation": "Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan."}}, {"@ValidYN": "Y", "LastName": "Akiyama", "ForeName": "Futoshi", "Initials": "F", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan."}, {"Affiliation": "Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan."}]}, {"@ValidYN": "Y", "LastName": "Ohno", "ForeName": "Shinji", "Initials": "S", "AffiliationInfo": {"Affiliation": "Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan."}}, {"@ValidYN": "Y", "LastName": "Saito", "ForeName": "Mitsue", "Initials": "M", "AffiliationInfo": {"Affiliation": "Department of Breast Oncology, Juntendo University, Tokyo, Japan."}}, {"@ValidYN": "Y", "LastName": "Arai", "ForeName": "Masami", "Initials": "M", "AffiliationInfo": [{"Affiliation": "Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan."}, {"Affiliation": "Diagnostics and Therapeutics of Intractable Disease, Graduate School of Medicine, Juntendo University, Tokyo, Japan."}]}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D002363", "#text": "Case Reports"}, {"@UI": "D016428", "#text": "Journal Article"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2019", "Month": "04", "Day": "12"}}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Breast Cancer", "NlmUniqueID": "100888201", "ISSNLinking": "1340-6868"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D019313", "#text": "BRCA1 Protein"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "C492913", "#text": "BRCA1 protein, human"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D024682", "#text": "BRCA2 Protein"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "C551750", "#text": "BRCA2 protein, human"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000328", "@MajorTopicYN": "N", "#text": "Adult"}}, {"DescriptorName": {"@UI": "D019313", "@MajorTopicYN": "N", "#text": "BRCA1 Protein"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D024682", "@MajorTopicYN": "N", "#text": "BRCA2 Protein"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": [{"@UI": "Q000175", "@MajorTopicYN": "Y", "#text": "diagnosis"}, {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}, {"@UI": "Q000601", "@MajorTopicYN": "N", "#text": "surgery"}]}, {"DescriptorName": {"@UI": "D055088", "@MajorTopicYN": "N", "#text": "Early Detection of Cancer"}, "QualifierName": {"@UI": "Q000379", "@MajorTopicYN": "N", "#text": "methods"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "N", "#text": "Genetic Predisposition to Disease"}}, {"DescriptorName": {"@UI": "D005820", "@MajorTopicYN": "N", "#text": "Genetic Testing"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D008279", "@MajorTopicYN": "N", "#text": "Magnetic Resonance Imaging"}}, {"DescriptorName": {"@UI": "D008327", "@MajorTopicYN": "N", "#text": "Mammography"}}, {"DescriptorName": {"@UI": "D008403", "@MajorTopicYN": "Y", "#text": "Mass Screening"}}, {"DescriptorName": {"@UI": "D008408", "@MajorTopicYN": "N", "#text": "Mastectomy"}}, {"DescriptorName": {"@UI": "D008875", "@MajorTopicYN": "N", "#text": "Middle Aged"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "Y", "#text": "Mutation"}}, {"DescriptorName": {"@UI": "D012306", "@MajorTopicYN": "N", "#text": "Risk"}}, {"DescriptorName": {"@UI": "D014041", "@MajorTopicYN": "N", "@Type": "Geographic", "#text": "Tokyo"}}, {"DescriptorName": {"@UI": "D016896", "@MajorTopicYN": "N", "#text": "Treatment Outcome"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "BRCA1 mutation carrier"}, {"@MajorTopicYN": "N", "#text": "BRCA2 mutation carrier"}, {"@MajorTopicYN": "N", "#text": "Breast cancer incidence"}, {"@MajorTopicYN": "N", "#text": "Screening-detected breast cancer"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2018", "Month": "12", "Day": "14"}, {"@PubStatus": "accepted", "Year": "2019", "Month": "04", "Day": "05"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2020", "Month": "2", "Day": "27", "Hour": "6", "Minute": "0"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "30980249"}, {"@IdType": "doi", "#text": "10.1007/s12282-019-00971-6"}, {"@IdType": "pii", "#text": "10.1007/s12282-019-00971-6"}, {"@IdType": "pmc", "#text": "PMC6821909"}]}, "ReferenceList": [{"Reference": {"Citation": "J Clin Oncol. 2004 Mar 15;22(6):1055-62", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "14981104"}}}}, {"Reference": {"Citation": "Ann Surg. 2014 Dec;260(6):1000-10", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24950272"}}}}, {"Reference": {"Citation": "J Clin Oncol. 2015 Apr 1;33(10):1128-35", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25713430"}}}}, {"Reference": {"Citation": "J Clin Oncol. 2012 Oct 1;30(28):3478-85", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22927521"}}}}, {"Reference": {"Citation": "AJR Am J Roentgenol. 2015 Apr;204(4):889-97", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25794083"}}}}, {"Reference": {"Citation": "BMJ. 2014 Feb 11;348:g226", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24519767"}}}}, {"Reference": {"Citation": "J Clin Oncol. 2016 Feb 10;34(5):409-18", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26700119"}}}}, {"Reference": {"Citation": "J Clin Oncol. 2011 May 1;29(13):1664-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21444874"}}}}, {"Reference": {"Citation": "Breast Cancer Res Treat. 2013 Dec;142(3):611-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24249359"}}}}, {"Reference": {"Citation": "JAMA. 2004 Sep 15;292(11):1317-25", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15367553"}}}}, {"Reference": {"Citation": "Breast Cancer Res Treat. 2013 Jul;140(1):135-42", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23784379"}}}}, {"Reference": {"Citation": "Int J Cancer. 2015 Feb 1;136(3):668-77", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24947112"}}}}, {"Reference": {"Citation": "Breast Cancer. 2016 May;23(3):343-56", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26873619"}}}}, {"Reference": {"Citation": "Breast Cancer Res Treat. 2017 Sep;165(2):433-444", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28624978"}}}}, {"Reference": {"Citation": "Clin Genet. 2011 May;79(5):431-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21199491"}}}}, {"Reference": {"Citation": "Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22144499"}}}}, {"Reference": {"Citation": "Ann Surg Oncol. 2015 Sep;22(9):2876-80", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25808098"}}}}]}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "31174498"}, "DateCompleted": {"Year": "2019", "Month": "11", "Day": "20"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"@PubModel": "Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1471-2407"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "19", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jun", "Day": "07"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.", "Pagination": {"MedlinePgn": "551"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1186/s12885-019-5765-3"}, "Abstract": {"AbstractText": [{"@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND", "#text": "Mutated BRCA1/2 genes are associated with hereditary breast and ovarian cancer (HBOC). So far most of the identified BRCA1/2 pathogenic variants are single nucleotide variants (SNVs) or insertions/deletions (Indels). However, large genomic rearrangements (LGRs) such as copy number variants (CNVs) are also playing an important role in HBOC predisposition. Their frequency and spectrum have been well studied in western populations but remain largely unknown for Chinese population."}, {"@Label": "METHODS", "@NlmCategory": "METHODS", "#text": "Peripheral blood samples were collected from 218 unrelated familial breast and/or ovarian cancer (FBOC) patients living in Eastern China. PCR-based Sanger sequencing and panel-based next-generation sequencing (NGS) were performed to detect pathogenic SNVs and Indels in BRCA1/2 genes. For the patients lacking small pathogenic variants, multiplex ligation dependent probe amplification (MLPA) assay was conducted to screen for LGRs."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "#text": "In total, we identified 44 samples (20.1%) carrying small pathogenic variants (26 in BRCA1 and 18 in BRCA2, respectively). Among the rest of 174 samples, five were found carrying novel deleterious LGRs in BRCA1 which are exon5-7dup (1 patient), exon13-14dup (2 patients), and exon1-22del (2 patients). No LGR was found in BRCA2. Overall, LGRs accounted for 16.1% (5/31) of BRCA1 pathogenic variants, and were detected in 2.3% (5/218) of all FBOC patients."}, {"@Label": ", CONCLUSIONS", "@NlmCategory": "UNASSIGNED", "#text": "LGR variants in BRCA1 gene play a significant role in Chinese HBOC patients. MLPA or other similar LGR-detecting methods should be recommended along with nucleotide sequencing as the initial screening approach for Chinese HBOC women."}]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Cao", "ForeName": "Wen-Ming", "Initials": "WM", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Zheng", "ForeName": "Ya-Bing", "Initials": "YB", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Gao", "ForeName": "Yun", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Institute of Cancer Research, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Ding", "ForeName": "Xiao-Wen", "Initials": "XW", "AffiliationInfo": {"Affiliation": "Department of Breast Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Sun", "ForeName": "Yan", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Huang", "ForeName": "Yuan", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Lou", "ForeName": "Cai-Jin", "Initials": "CJ", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Pan", "ForeName": "Zhi-Wen", "Initials": "ZW", "AffiliationInfo": {"Affiliation": "Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Peng", "ForeName": "Guang", "Initials": "G", "AffiliationInfo": {"Affiliation": "Department of Clinical Cancer Prevention, the University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA."}}, {"@ValidYN": "Y", "LastName": "Wang", "ForeName": "Xiao-Jia", "Initials": "XJ", "Identifier": {"@Source": "ORCID", "#text": "http://orcid.org/0000-0002-1084-0535"}, "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China. wxiaojia@yahoo.com."}}]}, "Language": "eng", "GrantList": {"@CompleteYN": "Y", "Grant": [{"GrantID": "81672597", "Agency": "National Natural Science Foundation of China", "Country": null}, {"GrantID": "LY17H160038", "Agency": "Natural Science Foundation of Zhejiang Province, China", "Country": null}, {"GrantID": "2012RCB006", "Agency": "Science and Technology Program offered by Health Bureau of Zhejiang Province, China", "Country": null}, {"GrantID": "2014KYA006", "Agency": "Science and Technology Program offered by Health Bureau of Zhejiang Province, China", "Country": null}, {"GrantID": "2017C03013", "Agency": "Key Research-Development Program of Zhejiang Province", "Country": null}, {"GrantID": "2019C04001", "Agency": "Key Research-Development Program of Zhejiang Province", "Country": null}]}, "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2019", "Month": "06", "Day": "07"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000483", "@MajorTopicYN": "N", "#text": "Alleles"}}, {"DescriptorName": {"@UI": "D019943", "@MajorTopicYN": "N", "#text": "Amino Acid Substitution"}}, {"DescriptorName": {"@UI": "D002681", "@MajorTopicYN": "N", "@Type": "Geographic", "#text": "China"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D015321", "@MajorTopicYN": "Y", "#text": "Gene Rearrangement"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "Y", "#text": "Genetic Predisposition to Disease"}}, {"DescriptorName": {"@UI": "D023281", "@MajorTopicYN": "Y", "#text": "Genomics"}, "QualifierName": {"@UI": "Q000379", "@MajorTopicYN": "N", "#text": "methods"}}, {"DescriptorName": {"@UI": "D005838", "@MajorTopicYN": "N", "#text": "Genotype"}}, {"DescriptorName": {"@UI": "D061325", "@MajorTopicYN": "N", "#text": "Hereditary Breast and Ovarian Cancer Syndrome"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "Y", "#text": "Mutation"}}, {"DescriptorName": {"@UI": "D010375", "@MajorTopicYN": "N", "#text": "Pedigree"}}, {"DescriptorName": {"@UI": "D020641", "@MajorTopicYN": "N", "#text": "Polymorphism, Single Nucleotide"}}, {"DescriptorName": {"@UI": "D017422", "@MajorTopicYN": "N", "#text": "Sequence Analysis, DNA"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "BRCA1"}, {"@MajorTopicYN": "N", "#text": "BRCA2"}, {"@MajorTopicYN": "N", "#text": "Chinese"}, {"@MajorTopicYN": "N", "#text": "Familial breast cancer"}, {"@MajorTopicYN": "N", "#text": "Familial ovarian cancer"}, {"@MajorTopicYN": "N", "#text": "Rearrangement"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2017", "Month": "08", "Day": "11"}, {"@PubStatus": "accepted", "Year": "2019", "Month": "05", "Day": "29"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2019", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "epublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "31174498"}, {"@IdType": "doi", "#text": "10.1186/s12885-019-5765-3"}, {"@IdType": "pii", "#text": "10.1186/s12885-019-5765-3"}, {"@IdType": "pmc", "#text": "PMC6555923"}]}, "ReferenceList": {"Reference": [{"Citation": "J Natl Cancer Inst. 1999 May 19;91(10):882-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10340909"}}}, {"Citation": "JAMA. 2006 Mar 22;295(12):1379-88", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16551709"}}}, {"Citation": "Clin Genet. 2007 Apr;71(4):331-42", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17470134"}}}, {"Citation": "Cancer Res. 2008 Sep 1;68(17):7006-14", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18703817"}}}, {"Citation": "Breast Cancer Res Treat. 2010 Sep;123(2):581-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20221693"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Jan;125(2):325-49", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20232141"}}}, {"Citation": "Breast Cancer Res Treat. 2010 Nov;124(2):579-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20617377"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Oct;129(3):1019-20", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21597919"}}}, {"Citation": "Genet Mol Biol. 2009 Jul;32(3):437-46", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21637503"}}}, {"Citation": "Breast Cancer Res Treat. 2012 May;133(1):273-83", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22434521"}}}, {"Citation": "J Epidemiol. 2013;23(2):75-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23318652"}}}, {"Citation": "Clin Chem Lab Med. 2014 Aug;52(8):1119-27", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24670361"}}}, {"Citation": "Lancet Oncol. 2014 Jun;15(7):e279-89", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24872111"}}}, {"Citation": "BMC Cancer. 2014 Sep 01;14:645", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25176351"}}}, {"Citation": "Genet Med. 2015 May;17(5):405-24", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25741868"}}}, {"Citation": "PLoS Genet. 2015 May 06;11(5):e1005228", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25945795"}}}, {"Citation": "Cancer Genet. 2015 Sep;208(9):448-54", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26271414"}}}, {"Citation": "CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26808342"}}}, {"Citation": "BMC Cancer. 2016 Feb 06;16:64", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26852015"}}}, {"Citation": "Int J Cancer. 2017 Jul 1;141(1):129-142", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28294317"}}}, {"Citation": "Clin Cancer Res. 2017 Oct 15;23(20):6113-6119", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28724667"}}}, {"Citation": "Int J Cancer. 2019 Jan 15;144(2):281-289", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "29752822"}}}, {"Citation": "Cancer Res. 1997 Mar 1;57(5):828-31", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9041180"}}}]}}}]}}